Navigation Links
Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer

Case History Highlighted in AACR Cancer Journal

AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today the publication of data describing the dramatic clinical benefit of its lead product Advexin in a patient with a rare inherited form of cancer known as Li-Fraumeni Syndrome (LFS), a genetic disorder characterized by inherited mutations in the p53 tumor suppressor gene. This is the first reported treatment of Li-Fraumeni tumors with a therapy targeted to the underlying molecular cause of the disorder. These cancers are due to inherited abnormalities of p53 function which is directly addressed by ADVEXIN treatment. In addition, the results of the study evaluated biomarkers which confirmed the molecular mechanism of activity of ADVEXIN. These biomarkers will guide ADVEXIN therapy of other cancers with p53 abnormalities, which is one of the most common molecular defects found in virtually all types of cancer.

The patient was treated as part of a study at the Mary Crowley Medical Research Center in Dallas, TX and the importance of the findings were underscored by publication this week in the Spotlight on Clinical Response editorial highlights section of the current issue of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

ADVEXIN treatment of a tumor in an LFS patient led to improvement of tumor-related symptoms and resulted in a complete response as determined by positron emission tomography (PET) scans. In addition, molecular biomarker studies using tumor biopsies before treatment detected abnormal levels of p53 protein predictive of ADVEXIN efficacy. Tumor biopsies analyzed after therapy identified restoration of p53 tumor suppressor function including suppression of tumor growth and induction of tumor cell death validating ADVEXIN's mechanisms of action.

"This case study showcases and provides p
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
2. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
(Date:9/16/2014)... , Sept. 16, 2014 Astellas ... director of Business Communications & Advocacy, Urology in ... Business Communications & Advocacy Margaret Long. In this role, ... to urology to patient and advocacy organizations, as ... on key strategic initiatives. Noland,s appointment is the ...
(Date:9/16/2014)... , Sept. 16, 2014 This report analyzes ... the following Product Segments: Devices, and Medication. The report provides ... , Japan , Europe ... , and Rest of World. Annual estimates and forecasts ... seven-year historic analysis is provided for these markets. Market data ...
(Date:9/16/2014)... Wash. , Sept. 16, 2014 /PRNewswire/ ... a late stage development company engaged primarily ... medical isotopes for diagnostic and therapeutic applications, ... for technology related to its brachytherapy products.  ... arise from its license from Battelle, under ...
Breaking Medicine Technology:Christy Noland to Lead Urology Advocacy and Communications for Astellas 2Global Foot Care Products Industry 2Global Foot Care Products Industry 3Global Foot Care Products Industry 4Global Foot Care Products Industry 5Global Foot Care Products Industry 6Global Foot Care Products Industry 7Global Foot Care Products Industry 8Global Foot Care Products Industry 9Global Foot Care Products Industry 10Global Foot Care Products Industry 11Global Foot Care Products Industry 12Global Foot Care Products Industry 13Global Foot Care Products Industry 14Global Foot Care Products Industry 15Global Foot Care Products Industry 16Global Foot Care Products Industry 17Global Foot Care Products Industry 18Global Foot Care Products Industry 19Global Foot Care Products Industry 20Global Foot Care Products Industry 21Global Foot Care Products Industry 22Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 4
... Inc. (NYSE: WPI ) and Actavis Group today ... to acquire privately held Actavis for an upfront payment of ... become the third largest global generics company with 2012 anticipated ... Actavis, which as a stand-alone company was positioned for strong ...
... PALO ALTO, Calif., April 25, 2012  Varian Medical Systems (NYSE: ... second quarter of fiscal year 2012 with net earnings of ... diluted share in the second quarter of fiscal year 2011.  ... include a $2.5 million or $0.02 per diluted share restructuring ...
Cached Medicine Technology:Watson to Acquire Actavis Group for EUR4.25 Billion 2Watson to Acquire Actavis Group for EUR4.25 Billion 3Watson to Acquire Actavis Group for EUR4.25 Billion 4Watson to Acquire Actavis Group for EUR4.25 Billion 5Watson to Acquire Actavis Group for EUR4.25 Billion 6Watson to Acquire Actavis Group for EUR4.25 Billion 7Watson to Acquire Actavis Group for EUR4.25 Billion 8Watson to Acquire Actavis Group for EUR4.25 Billion 9Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 2Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 3Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 4Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 5Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 6Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 7Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012 8
(Date:9/17/2014)... September 17, 2014 In honor of ... offers tips to health IT professionals for gaining a ... recent study by HIMSS shows demand for qualified health ... candidate’s skill set is the differentiating factor when filling ... an IT professional that has clinical workflow and terminology ...
(Date:9/17/2014)... On October 1-2, Voom will be adding their ... a celebration of the intersection of life and technology. ... will host the best and brightest across the tech ... Cisco, PayPal, Samsung, Silicon Valley Bank, and Adobe in ... Voom was created to address the health concerns shaped ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 ... Center software, has launched Presence Suite 10.0, which ... and improve the customer experience. , The Contact ... and flexibility. Now supervisors can get a better ... understand who is contributing most and who requires ...
(Date:9/16/2014)... Top10BestSEOHosting.com has recently compared many CEO ... for the webmasters that want to buy high ... The senior spokesman for Top10BestSEOHosting.com says, “We believe ... are the excellent hosting companies for worldwide people. ... range of advanced features while still maintaining an ...
(Date:9/16/2014)... socioeconomic groups in the UK report a poorer experience ... a greater focus on their care, suggests a new ... International Journal of Obstetrics and Gynaecology ( BJOG ... groups have been demonstrated in many areas and have ... to reduce the observed inequalities. , The Oxford University ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2
... seeking help for drug abuse, study finds , WEDNESDAY, June ... admissions for drug abuse treatment have nearly doubled between 1992 ... heroin, prescription drugs, and/or marijuana abuse among men and women ... to just over 12 percent by 2008, according to researchers ...
... event of the year: the Living Planet Symposium, in ... observation, highlighting the results and ESA,s planned missions, as ... worldwide. In addition to presenting the contributions that ... our understanding of Earth,s environment and climate change over ...
... free-range eggs may not be healthier than eating regular eggs, ... Taiwan contain at least five times higher levels of certain ... Journal of Agricultural and Food Chemistry . In ... chickens are those that have continuous access to fresh air, ...
... will enhance the breakdown of oil from the Gulf of ... the topics in a comprehensive status report that is the ... ACS, weekly newsmagazine. C&EN Senior Correspondent Jeff Johnson ... government and industry officials continue to struggle with how to ...
... ... Davis Company, recruits bloggers to post learning points from the APTA 2010 conference this ... ... online continuing education resource for physical therapy professionals— DavisPTnetwork — has recruited several ...
... three quarters (72%) of women with Rheumatoid Arthritis (RA) suffer ... pain relief medication, according to a new study presented today ... Against Rheumatism in Rome, Italy. Furthermore the physical pain ... impacts negatively on emotional and social aspects of their lives. ...
Cached Medicine News:Health News:'Graying' of Drug Users at U.S. Treatment Centers 2Health News:Call for Media: ESA's Living Planet Symposium, Bergen, June 28 - July 2 2Health News:DavisPTnetwork Recruits Bloggers to Report Key Session Learning Points Live from APTA 2010 2Health News:Almost three quarters of women with rheumatoid arthritis worldwide suffer pain daily 2
Assay for Anti-PR3 IgG....
... technology relates to the ultrasensitive measurement of ... all living cells. ATP produced by ... By coupling AK Technology to ... using antibody-coated beads, Acolyte can measure bacteria ...
... a differential medium designed for the ... Selective agents are incorporated for the ... of S. epidermidis and yeast. S. ... in mauve colonies, thus permitting differentiation ...
... cleared by the FDA and by Health Canada ... methicillin resistant Staphylococcus aureus (MRSA). Based on the ... in about one hour after the collection of ... require two to five days. By detecting a ...
Medicine Products: